AbCellera Biologics, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1285993,
    "name": "AbCellera Biologics, Inc.",
    "stock_name": "AbCellera Biologics, Inc.",
    "full_name": "AbCellera Biologics, Inc.",
    "name_url": "stocks-analysis/abcellera-biologics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "3.65",
    "chg": 0.19,
    "chgp": "5.49%",
    "dir": 1,
    "prev_price": "3.46",
    "mcapval": "1,246.13",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "CA00288U1066",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "7.41 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abcellera-biologics-inc-1285993-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "AbCellera Biologics Hits Day Low of $3.42 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-day-low-of-342-amid-price-pressure-3686568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AbCelleraBiolog_priceRelatedfactors_3686568.png",
        "date": "2025-11-10 17:53:36",
        "description": "AbCellera Biologics, Inc. faced notable stock volatility on November 7, 2025, with a significant decline amid contrasting market performance. The company has struggled with negative results over the past ten quarters, low liquidity indicators, and a market capitalization of USD 1,246 million, classifying it as a small-cap entity."
      },
      {
        "title": "AbCellera Biologics Hits Day Low of $4.67 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-day-low-of-467-amid-price-pressure-3676154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AbCelleraBiolog_priceRelatedfactors_3676154.png",
        "date": "2025-11-06 16:20:08",
        "description": "AbCellera Biologics, Inc. faced a notable decline in stock value, contrasting with the broader market's performance. Despite recent setbacks and negative results over ten quarters, the company has shown strong year-over-year growth. Institutional investors maintain significant holdings, indicating ongoing confidence in its fundamentals amid current challenges."
      },
      {
        "title": "AbCellera Biologics Hits Day High with 8.54% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-day-high-with-854-surge-in-stock-price-3626738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbCelleraBiolog_priceRelatedfactors_3626738.png",
        "date": "2025-10-16 19:04:03",
        "description": "AbCellera Biologics, Inc. saw a notable rise in stock performance on October 15, 2025, reaching an intraday high. Despite a strong annual return, the company has struggled with negative results over the past ten quarters and faces financial challenges, though institutional holdings have increased, reflecting investor confidence."
      },
      {
        "title": "AbCellera Biologics Hits New 52-Week High of $6.51",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-new-52-week-high-of-651-3608056",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbCelleraBiolog_priceRelatedfactors_3608056.png",
        "date": "2025-10-09 20:23:18",
        "description": "AbCellera Biologics, Inc. achieved a new 52-week high of USD 6.51 on October 8, 2025, reflecting significant growth from its previous low. The company has outperformed the S&P 500 over the past year, although it continues to report losses and has notable financial metrics indicating its market position."
      },
      {
        "title": "AbCellera Biologics Hits New 52-Week High of $6.41, Up 68% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-new-52-week-high-of-641-up-68-year-to-date-3595675",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbCelleraBiolog_priceRelatedfactors_3595675.png",
        "date": "2025-10-06 17:40:26",
        "description": "AbCellera Biologics, Inc. achieved a new 52-week high of USD 6.41 on October 3, 2025, reflecting a strong performance over the past year. The company, with a market capitalization of USD 1,246 million, has outperformed the S&P 500, despite reporting losses and a negative return on equity."
      },
      {
        "title": "AbCellera Biologics Hits New 52-Week High of $5.97",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-new-52-week-high-of-597-3588405",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbCelleraBiolog_priceRelatedfactors_3588405.png",
        "date": "2025-10-02 22:39:51",
        "description": "AbCellera Biologics, Inc. achieved a new 52-week high of USD 5.97 on October 1, 2025, reflecting a significant increase from its previous low. The company has shown a 69.8% rise in stock price over the past year, despite being in a loss-making position and lacking dividends."
      },
      {
        "title": "AbCellera Biologics Hits Day High with 8.17% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-day-high-with-817-surge-in-stock-price-3585911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbCelleraBiolog_priceRelatedfactors_3585911.png",
        "date": "2025-10-01 16:19:23",
        "description": "AbCellera Biologics, Inc. saw a notable rise in stock performance on September 30, 2025, with significant gains over the past week and month. Despite impressive annual returns, the company has faced challenges, including negative results for ten consecutive quarters and declining profits, alongside strong institutional investor confidence."
      },
      {
        "title": "AbCellera Biologics Hits Day High with 7.1% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-day-high-with-71-surge-in-stock-price-3559178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AbCelleraBiolog_priceRelatedfactors_3559178.png",
        "date": "2025-09-23 15:09:25",
        "description": "AbCellera Biologics, Inc. has demonstrated strong stock performance, significantly outperforming the S&P 500 over various timeframes. Despite facing challenges with negative results for the past ten quarters and concerning financial metrics, institutional holdings indicate confidence from larger investors, reflecting the company's complex market position."
      },
      {
        "title": "AbCellera Biologics Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-inc-technical-trend-upgrades-from-mildly-bullish-to-bullish-amid-stock-fluctuations-3552696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AbCelleraBiolog_technicaldot_3552696.png",
        "date": "2025-09-22 18:22:20",
        "description": "AbCellera Biologics, Inc. has recently adjusted its market evaluation, with its stock priced at $4.51. Over the past year, the company has achieved a notable 64.6% return, significantly outperforming the S&P 500. Technical indicators present a mixed outlook, reflecting both bullish and cautious sentiments."
      }
    ],
    "total": 16,
    "sid": "1285993",
    "stock_news_url": "https://www.marketsmojo.com/news/abcellera-biologics-inc-1285993"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

AbCellera Biologics Hits Day Low of $3.42 Amid Price Pressure

2025-11-10 17:53:36

AbCellera Biologics, Inc. faced notable stock volatility on November 7, 2025, with a significant decline amid contrasting market performance. The company has struggled with negative results over the past ten quarters, low liquidity indicators, and a market capitalization of USD 1,246 million, classifying it as a small-cap entity.

AbCellera Biologics Hits Day Low of $4.67 Amid Price Pressure

2025-11-06 16:20:08

AbCellera Biologics, Inc. faced a notable decline in stock value, contrasting with the broader market's performance. Despite recent setbacks and negative results over ten quarters, the company has shown strong year-over-year growth. Institutional investors maintain significant holdings, indicating ongoing confidence in its fundamentals amid current challenges.

AbCellera Biologics Hits Day High with 8.54% Surge in Stock Price

2025-10-16 19:04:03

AbCellera Biologics, Inc. saw a notable rise in stock performance on October 15, 2025, reaching an intraday high. Despite a strong annual return, the company has struggled with negative results over the past ten quarters and faces financial challenges, though institutional holdings have increased, reflecting investor confidence.

AbCellera Biologics Hits New 52-Week High of $6.51

2025-10-09 20:23:18

AbCellera Biologics, Inc. achieved a new 52-week high of USD 6.51 on October 8, 2025, reflecting significant growth from its previous low. The company has outperformed the S&P 500 over the past year, although it continues to report losses and has notable financial metrics indicating its market position.

AbCellera Biologics Hits New 52-Week High of $6.41, Up 68% Year-to-Date

2025-10-06 17:40:26

AbCellera Biologics, Inc. achieved a new 52-week high of USD 6.41 on October 3, 2025, reflecting a strong performance over the past year. The company, with a market capitalization of USD 1,246 million, has outperformed the S&P 500, despite reporting losses and a negative return on equity.

AbCellera Biologics Hits New 52-Week High of $5.97

2025-10-02 22:39:51

AbCellera Biologics, Inc. achieved a new 52-week high of USD 5.97 on October 1, 2025, reflecting a significant increase from its previous low. The company has shown a 69.8% rise in stock price over the past year, despite being in a loss-making position and lacking dividends.

AbCellera Biologics Hits Day High with 8.17% Surge in Stock Price

2025-10-01 16:19:23

AbCellera Biologics, Inc. saw a notable rise in stock performance on September 30, 2025, with significant gains over the past week and month. Despite impressive annual returns, the company has faced challenges, including negative results for ten consecutive quarters and declining profits, alongside strong institutional investor confidence.

AbCellera Biologics Hits Day High with 7.1% Surge in Stock Price

2025-09-23 15:09:25

AbCellera Biologics, Inc. has demonstrated strong stock performance, significantly outperforming the S&P 500 over various timeframes. Despite facing challenges with negative results for the past ten quarters and concerning financial metrics, institutional holdings indicate confidence from larger investors, reflecting the company's complex market position.

AbCellera Biologics Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-09-22 18:22:20

AbCellera Biologics, Inc. has recently adjusted its market evaluation, with its stock priced at $4.51. Over the past year, the company has achieved a notable 64.6% return, significantly outperforming the S&P 500. Technical indicators present a mixed outlook, reflecting both bullish and cautious sentiments.

View All News